Bio-Techne(TECH) - 2025 Q2 - Quarterly Results

Kelderman added, "The Bio-Techne growth vectors empower the discovery of novel biological insights, the development and manufacturing of advanced therapeutics and, enable precision diagnostics. Our portfolio plays a key role in the healthy aging of global populations. The combination of this unique portfolio with the talented Bio-Techne team positions the Company for continued differentiated financial performance." Exhibit 99.1 BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2025 RESULTS Minneapolis/February 5, 2 ...